SEC 13F Intelligence

Managers / Q1 2020 · view latest →

EVENTIDE ASSET MANAGEMENT, LLC

CIK 0001442891 · ONE INTERNATIONAL PLACE, SUITE 4210, BOSTON, MA, 02110 · 877-771-3836

Reported Value
$3.1B
Q1 2020
Positions
122
Filings on Record
31
2019–present window
Filed
May 15, 2020
original filing

Summary

Eventide Asset Management, LLC reported $3.1B in U.S.-listed holdings across 122 positions for Q1 2020.

Its largest position, Ascendis Pharma A S, represents 6.2% of the portfolio.

Compared with Q4 2019, the fund opened 26 new positions and exited 21.

Portfolio Metrics

Turnover
+16.9%
vs prior filed quarter
Top-10 Concentration
+27.5%
share of reported value
Largest Position
+6.2%
Ascendis Pharma A S
New / Exited
26 / 21
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $2.3BQ4 ’18Q1 ’19: $2.9BQ2 ’19: $3.3BQ3 ’19: $3.0BQ4 ’19: $3.5BQ4 ’19Q1 ’20: $3.1BQ2 ’20: $4.6BQ3 ’20: $5.1BQ4 ’20: $6.5BQ4 ’20Q1 ’21: $6.7BQ2 ’21: $7.4BQ3 ’21: $7.6BQ4 ’21: $7.8BQ4 ’21Q1 ’22: $6.4BQ2 ’22: $4.7BQ3 ’22: $5.1BQ4 ’22: $5.1BQ4 ’22Q1 ’23: $5.5BQ2 ’23: $5.9BQ3 ’23: $5.6BQ4 ’23: $6.1BQ4 ’23Q1 ’24: $6.4BQ2 ’24: $5.8BQ3 ’24: $5.8BQ4 ’24: $5.5BQ4 ’24Q1 ’25: $5.0BQ2 ’25: $5.7BQ3 ’25: $6.1BQ4 ’25: $6.4BQ4 ’25Q1 ’26: $6.0Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 74.8%Other: 18.5%ADR: 2.9%ETP: 2.0%REIT: 1.7%Other: 0.1%
  • Common Stock · 74.8% · $2.3B
  • Other · 18.5% · $572M
  • ADR · 2.9% · $89M
  • ETP · 2.0% · $62M
  • REIT · 1.7% · $51M
  • Other · 0.1% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ISHARES TRNEW+291.0K291.0K+$62M$62M
CRWDCROWDSTRIKE HLDGS INCNEW+987.0K987.0K+$55M$55M
ROLROLLINS INCNEW+773.0K773.0K+$28M$28M
KALA PHARMACEUTICALS INCNEW+2.95M2.95M+$26M$26M
RNGRINGCENTRAL INCNEW+121.0K121.0K+$26M$26M
VRSKVERISK ANALYTICS INCNEW+158.0K158.0K+$22M$22M
REGNREGENERON PHARMACEUTICALSNEW+30.9K30.9K+$15M$15M
XLRNACCELERON PHARMA INCNEW+142.9K142.9K+$13M$13M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

48 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ASCENDIS PHARMA A SSPONSORED ADR6.19%$191M1.70M
2SRPTSAREPTA THERAPEUTICS INChistory →COM3.16%$97M996.0K
3FIVNFIVE9 INChistory →COM3.02%$93M1.22M
4EXKEXACT SCIENCES CORPhistory →COM2.61%$81M1.39M
5ZGNXEURZOGENIX INChistory →COM NEW2.28%$70M2.84M
6ROPROPER TECHNOLOGIES INChistory →COM2.16%$67M214.0K
7KARUNA THERAPEUTICS INCCOM2.10%$65M901.1K
8WCNWASTE CONNECTIONS INChistory →COM2.02%$62M804.0K
9TWLOTWILIO INChistory →CL A1.99%$61M685.0K
10BIOHAVEN PHARMACTL HLDG CO LCOM1.97%$61M1.78M
11TTDTHE TRADE DESK INChistory →COM CL A1.87%$58M300.0K
12AIMTAIMMUNE THERAPEUTICS INChistory →COM1.80%$56M3.85M
13CRWDCROWDSTRIKE HLDGS INChistory →CL A1.78%$55M987.0K
14SPLKCHFSPLUNK INChistory →COM1.75%$54M428.0K
15XIFRNEXTERA ENERGY PARTNERS LPhistory →COM UNIT PART IN1.73%$53M1.24M
16XYLXYLEM INChistory →COM1.67%$52M793.0K
17LOWLOWES COS INChistory →COM1.66%$51M596.6K
18DTDYNATRACE INChistory →COM1.60%$50M2.08M
19MTDMETTLER TOLEDO INTERNATIONALhistory →COM1.59%$49M71.0K
20LRCXEURLAM RESEARCH CORPhistory →COM1.56%$48M201.0K
21LIILENNOX INTL INChistory →COM1.50%$46M255.0K
22ASML HOLDING N VN Y REGISTRY SHS1.46%$45M172.0K
23HUBSHUBSPOT INChistory →COM1.43%$44M332.0K
24VMCVULCAN MATLS COhistory →COM1.41%$43M401.7K
25COLLCOLLEGIUM PHARMACEUTICAL INChistory →COM1.28%$40M2.43M
26SMARGBPSMARTSHEET INChistory →COM CL A1.27%$39M947.0K
27ARGXARGENX SEhistory →SPONSORED ADR1.27%$39M297.3K
28BROOKFIELD RENEWABLE PARTNERPARTNERSHIP UNIT1.26%$39M916.2K
298CWCROWN CASTLE INTL CORP NEWhistory →COM1.24%$38M265.9K
30GW PHARMACEUTICALS PLCADS1.24%$38M436.0K
31POOLPOOL CORPORATIONhistory →COM1.19%$37M186.0K
32IPHIINPHI CORPhistory →COM1.15%$36M450.0K
33IDXXIDEXX LABS INChistory →COM1.12%$35M143.0K
34MNTAMOMENTA PHARMACEUTICALS INChistory →COM1.07%$33M1.21M
35WWAYFAIR INChistory →CL A0.99%$31M573.0K
36NBIXNEUROCRINE BIOSCIENCES INChistory →COM0.99%$31M353.0K
37AVROBIO INCCOM0.96%$30M1.91M
38MYOKEURMYOKARDIA INChistory →COM0.94%$29M621.0K
39ODFLOLD DOMINION FREIGHT LINE INhistory →COM0.91%$28M213.5K
40ROLROLLINS INChistory →COM0.90%$28M773.0K
41APTIV PLCSHS0.89%$27M556.5K
42GBTUSDGLOBAL BLOOD THERAPEUTICS INhistory →COM0.89%$27M535.0K
432655787DBLUEPRINT MEDICINES CORPhistory →COM0.87%$27M462.0K
44VRNSVARONIS SYS INChistory →COM0.87%$27M420.0K
45KALA PHARMACEUTICALS INCCOM0.84%$26M2.95M
46RNGRINGCENTRAL INChistory →CL A0.83%$26M121.0K
47TREXTREX CO INChistory →COM0.78%$24M299.0K
48UNIQURE NVSHS0.77%$24M500.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$6.0B278May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$6.4B268Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$6.1B240Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$5.7B237Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$5.0B217May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$5.5B204Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$5.8B180Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$5.8B161Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$6.4B157May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$6.1B152Feb 20, 2024RESTATEMENTchanges · EDGAR ↗
Q3 2023$5.6B155Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$5.9B139Aug 15, 202313F-HRchanges · EDGAR ↗
Q1 2023$5.5B149May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$5.1B143Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$5.1B138Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$4.7B136Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$6.4B136May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$7.8B146Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$7.6B152Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$7.4B152Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$6.7B156May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$6.5B158Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$5.1B142Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$4.6B134Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$3.1B122May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$3.5B116Jan 29, 202013F-HRchanges · EDGAR ↗
Q3 2019$3.0B124Nov 21, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.3B116Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$2.9B131May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$2.3B134Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.